|

Lanreotide Clinical Trials

3 actively recruiting trials across 2 locations

Also known as: Angiopeptin, BIM-23014, DC 13116, Dermopeptin, Ipstyl, Somatulina, Somatuline

Other1 trial

Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors
Phase 1/2

Birmingham, Alabama1 trial

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

University of Alabama at Birmingham Cancer Center

Phase 3

Phoenix, Arizona1 trial

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Research Facility

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.